Prof. Yueyin Pan 潘跃银
Chief Physician, Professor
Department of Radiation Oncology (II), Anhui Provincial Cancer Hospital, Hefei
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of breast hyperplasia, breast nodules, and breast cancer. Specializes in pharmacological, immunological, and molecular targeted therapies for breast cancer.
Dr. Pan is a Professor, Chief Physician, and PhD supervisor. A visiting scholar at Dana-Farber Cancer Institute (2007-2008) and trained at Institut Curie-Paris. Dr. Pan serves as Vice President of the West District of the First Affiliated Hospital of USTC. The doctor has led or participated in over 60 multi-center clinical trials and published more than 100 papers, including 35 in SCI journals.
Professional roles
- Vice Chair, Breast Disease Branch, Chinese Medical Association (Anhui)
- Standing Committee Member, Breast Cancer Expert Committee, Chinese Society of Clinical Oncology (CSCO)
- Chair, Breast Cancer Professional Committee, Anhui Anti-Cancer Association
- Member, Breast Cancer Professional Committee, China Anti-Cancer Association (CACA)
Name order: in Chinese the family name comes first (Pan Yueyin). Papers usually list the name as Yueyin Pan or Pan Y.
Selected publications
24 papers on PubMed matched by name and affiliation; 7 as first or senior author since 2016. Most recent first- or senior-author papers:
- Transl Cancer Res, 2026 (senior author): Personalized prediction of sequential therapeutic responses in HR+/HER2-low breast cancer using patient-derived organoids. PubMed 42870875
- J Pharm Anal, 2025 (senior author): Synergistic approach to combating triple-negative breast cancer: DDR1-targeted antibody-drug conjugate combined with pembrolizumab. PubMed 40521369
- Ann Transl Med, 2023 (senior author): CircRBM33 promotes migration, invasion and mediates osimertinib resistance in non-small cell lung cancer cell line. PubMed 37082696
- Gland Surg, 2020 (senior author): The correlation between blood lipids and clinicopathological features of breast cancer in young females. PubMed 33224819
- Gland Surg, 2020 (senior author): Standard-dose epirubicin increases the pathological complete response rate in neoadjuvant chemotherapy for breast cancer: a multicenter retrospective study. PubMed 32953611
- J Thorac Oncol, 2019 (senior author): Acquired Mechanism of Crizotinib Resistance in NSCLC with MET Exon 14 Skipping. PubMed 31055074
- Intern Med J, 2017 (senior author): Relationship between Helicobacter pylori infection and vomiting induced by gastrointestinal cancer chemotherapy. PubMed 28321977
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion